THE DAILY REFORMER (NEW YORK, UNITED STATES)
February 23, 2021
NEW YORK (Reuters) – Johnson & Johnson expects to be able to ship nearly 4 million doses of its COVID-19 vaccine upon authorization in the U.S., an executive said at a hearing in the U.S. House of Representatives on Tuesday.
The single-dose vaccine is being considered by an outside advisory committee to the U.S. Food and Drug Administration later this week, and emergency use authorization could come shortly afterward.
Richard Nettles, Vice President of Medical Affairs at J&J unit Janssen Pharmaceutical, said the company expects to deliver 20 million doses of the vacine by the end of March.
(Reporting by Michael Erman)
As reported by One America News Network. Continue reading this article at One America News Network
All news text, graphics, videos and multimedia content remain the copyrights of the credited original article publisher, in this case - One America News Network
The Daily Reformer is an American conservative news aggregator and publisher with a mission to provide "the smart take on American conservative news.
Contact Information: amnon (at) thedailyreformer dot com